Christopher Stone
2013
In 2013, Christopher Stone earned a total compensation of $1.3M as Vice President, General Counsel and Secretary at PDL BioPharma, a 9% increase compared to previous year.
Compensation breakdown
| Bonus | $258,000 |
|---|---|
| Non-Equity Incentive Plan | $559,275 |
| Salary | $401,700 |
| Stock Awards | $110,600 |
| Other | $10,000 |
| Total | $1,339,575 |
Stone received $559.3K in non-equity incentive plan, accounting for 42% of the total pay in 2013.
Stone also received $258K in bonus, $401.7K in salary, $110.6K in stock awards and $10K in other compensation.
Rankings
In 2013, Christopher Stone's compensation ranked 5,398th out of 12,286 executives tracked by ExecPay. In other words, Stone earned more than 56.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,398 out of 12,286 | 56th |
Division Manufacturing | 1,874 out of 4,612 | 59th |
Major group Chemicals And Allied Products | 537 out of 1,462 | 63rd |
Industry group Drugs | 382 out of 1,156 | 67th |
Industry Biological Products, Except Diagnostic Substances | 58 out of 196 | 70th |
Source: SEC filing on April 20, 2016.
Stone's colleagues
We found five more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2013.
2013
John McLaughlin
PDL BioPharma
Chief Executive Officer
2013
Danny Hart
PDL BioPharma
Vice President, Business Development
2013
Peter Garcia
PDL BioPharma
Chief Financial Officer
2013
David Montez
PDL BioPharma
Chief Accounting Officer
2013
Caroline Krumel
PDL BioPharma